DealsCapiton completes single-asset process for KD Pharma GroupPantheon and Aberdeen Standard Investments led the deal alongside other investors.ByChris Witkowsky20 February 2020•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareSecondariesBriefs